A Study of Pharmacogenomics (PGx) Results and Clinical Data of Chronic Pain Patients to Assess Current and Future Therapeutic Relevance

Overview

About this study

The purpose of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of chronic pain patients in order to improve patient clinical care at Mayo Clinic with more effective and efficient prescribing of medications.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

A Mayo Clinic patient within the Pain Division piloting PGx testing with the Center for Individualized Medicine, seeking clinical information from emerging PGx testing technologies available in CLIA/CAP laboratories
Patient age 18 or above
Patient must reside in a county within a 100 mile radius of Rochester, MN
Patient must be taking a medication of interest (classes of medications include TCA, SNRI, opioid, or benzodiazepine)
Patients must understand and provide written informed consent and HIPAA authorization prior to initiation of any study-specific procedures
Patient is willing to engage in a medication assessment as part of their clinical visit preparation (when needed)

Exclusion Criteria

Patient with uncontrolled concurrent illness including psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator William Mauck, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

William Mauck, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials